Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
![Foto de Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)](/img/noimage.png)
![Foto de Hospital Universitario Arnau de Vilanova](/img/noimage_org.png)
Hospital Universitario Arnau de Vilanova
Lleida, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Arnau de Vilanova (23)
2023
-
Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction
Journal of Clinical Medicine, Vol. 12, Núm. 8
2022
-
Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
Frontiers in Cardiovascular Medicine, Vol. 9
2021
-
Effect of COMBinAtion therapy with remote ischemic conditioning and exenatide on the Myocardial Infarct size: a two-by-two factorial randomized trial (COMBAT-MI)
Basic Research in Cardiology, Vol. 116, Núm. 1
-
Ischemic etiology and prognosis in men and women with acute heart failure
Journal of Clinical Medicine, Vol. 10, Núm. 8
-
Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice
REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48
-
Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction
Internal Medicine Journal, Vol. 51, Núm. 6, pp. 930-938
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2019
-
Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study
Human Pathology, Vol. 89, pp. 90-98
-
Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction
Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513
-
Patient-Associated Predictors of 15- and 30-Day Readmission After Hospitalization for Acute Heart Failure
Current Heart Failure Reports, Vol. 16, Núm. 6, pp. 304-314
2018
-
Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study
International Journal of Gynecological Cancer, Vol. 28, Núm. 3, pp. 514-523
-
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Annals of Oncology, Vol. 29, Núm. 6, pp. 1454-1460
-
Influence of sex and pregnancy on survival in patients admitted with heart failure: Data from a prospective multicenter registry
Clinical Cardiology, Vol. 41, Núm. 7, pp. 924-930
2016
-
Competencias profesionales y trabajo en equipo en pacientes con enfermedades cardiacas agudas y críticas. Respuesta
Revista Espanola de Cardiologia
-
L1CAM expression in endometrial carcinomas: An ENITEC collaboration study
British Journal of Cancer, Vol. 115, Núm. 6, pp. 716-724
-
The Healthcare of Patients with Acute and Critical Heart Disease. Position of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 69, Núm. 3, pp. 239-242
2014
-
A unified nomenclature and amino acid numbering for human PTEN
Science Signaling, Vol. 7, Núm. 332
2013
-
Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure
European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884
-
Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility
PLoS ONE, Vol. 8, Núm. 9
-
Pharmacogenomics in colorectal cancer: A genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration
Pharmacogenomics Journal, Vol. 13, Núm. 3, pp. 209-217